BIO-Key International Inc (NASDAQ:BKYI) — Stock Price
BIO-Key International Inc (NASDAQ:BKYI) is currently trading at $4.17 USD, up 3.47% today. Over the past 52 weeks, shares have ranged between $0.46 and $5.86. This page tracks BIO-Key International Inc's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BIO-Key International Inc market cap and net worth.
BIO-Key International Inc (BKYI) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BIO-Key International Inc's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
BIO-Key International Inc Income Statement — Revenue, Profit & Earnings by Year
BIO-Key International Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $6.10 Million | $6.93 Million | $7.75 Million | $7.02 Million | $5.11 Million |
| Cost of Revenue | $1.37 Million | $1.29 Million | $6.32 Million | $2.44 Million | $1.67 Million |
| Gross Profit | $4.72 Million | $5.64 Million | $1.43 Million | $4.58 Million | $3.44 Million |
| Research & Development | $2.61 Million | $2.51 Million | $2.39 Million | $3.25 Million | $2.36 Million |
| SG&A | — | $7.14 Million | $8.47 Million | $9.64 Million | $6.03 Million |
| Total Operating Expenses | $8.98 Million | $9.65 Million | $10.26 Million | $14.50 Million | $8.38 Million |
| Operating Income | $-4.26 Million | $-4.01 Million | $-8.83 Million | $-9.92 Million | $-4.94 Million |
| EBITDA | $-3.88 Million | $-3.55 Million | $-7.85 Million | $-11.37 Million | $-4.53 Million |
| EBIT | $-4.26 Million | $-4.02 Million | $-8.44 Million | $-11.92 Million | $-5.05 Million |
| Interest Expense | $317.63K | $299.75K | $218.27K | $10.46K | $18.00K |
| Income Before Tax | $-4.57 Million | $-4.32 Million | $-8.66 Million | $-11.93 Million | $-5.07 Million |
| Income Tax Expense | $-16.50K | $-23.00K | $-134.01K | $-20.43K | $-496.07K |
| Net Income | $-4.59 Million | $-4.30 Million | $-8.52 Million | $-11.91 Million | $-5.07 Million |
BIO-Key International Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BIO-Key International Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $10.87 Million | $8.62 Million | $4.52 Million | $11.34 Million | $17.77 Million |
| Total Current Assets | $4.60 Million | $1.89 Million | $2.62 Million | $8.98 Million | $14.01 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | $5.00 Billion | — | — | $0.00 |
| Net Receivables | $1.24 Million | $792.40K | $1.30 Million | $1.57 Million | $1.10 Million |
| Inventory | $370.88K | $378.31K | $445.74K | $4.43 Million | $4.94 Million |
| Property, Plant & Equipment | — | — | — | — | $323.27K |
| Goodwill | — | — | — | $0.00 | $1.26 Million |
| Total Liabilities | $3.20 Million | $4.84 Million | $3.45 Million | $6.04 Million | $2.15 Million |
| Total Current Liabilities | $3.10 Million | $4.55 Million | $3.21 Million | $5.46 Million | $2.00 Million |
| Long-term Debt | — | $44.76K | $188.79K | $120.00K | — |
| Net Debt | $-2.65 Million | $1.34 Million | $-146.05K | $604.94K | $-7.49 Million |
| Total Stockholder Equity | $7.67 Million | $3.77 Million | $1.06 Million | $5.30 Million | $15.62 Million |
| Retained Earnings | $-133.90 Million | $-129.31 Million | $-125.01 Million | $-116.49 Million | $-104.58 Million |
BIO-Key International Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BIO-Key International Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-4.66 Million | $-2.91 Million | $-3.79 Million | $-6.23 Million | $-8.98 Million |
| Capital Expenditures | $12.01K | $13.05K | $1.00K | $82.04K | $42.02K |
| Free Cash Flow | $-4.67 Million | $-2.93 Million | $-3.79 Million | $-6.31 Million | $-9.02 Million |
| Investing Cash Flow | $-12.01K | $-13.05K | $-1.00K | $-696.62K | $-42.02K |
| Financing Cash Flow | $6.91 Million | $2.83 Million | $1.43 Million | $1.90 Million | $-218.60K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $146.57K | $243.25K | $265.73K | $387.91K | $314.71K |
| Depreciation | $351.73K | $477.53K | $590.14K | $546.01K | $514.07K |
| Change in Cash | $2.26 Million | $-73.80K | $-2.12 Million | $-5.12 Million | $-9.24 Million |
BIO-Key International Inc Earnings History — EPS Actual vs. Analyst Estimates
Track BIO-Key International Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2026 | -1.85 | — | — |
| Nov 14, 2025 | -0.15 | -0.12 | -25.00% |
| Aug 12, 2025 | -0.20 | -0.15 | -33.53% |
| May 19, 2025 | -0.15 | -0.24 | +39.46% |
| Mar 31, 2025 | -0.52 | -0.35 | -47.66% |
| Nov 18, 2024 | -0.39 | -0.58 | +32.59% |
| Aug 14, 2024 | -1.00 | -0.54 | -85.19% |
| Jun 17, 2024 | -2.88 | -4.14 | +30.43% |